Search for: "ACT, Inc." Results 1 - 20 of 57,607
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2012, 4:18 pm by Cynthia Marcotte Stamer
A False Claims Act settlement announced last week with Arizona-based urgent care chain NextCare Inc. provides another illustration of the growing exposure that qui tam and other reports of illegal practices by employees, contractors and other business partners create for health care and other companies. [read post]
16 Jun 2023, 8:32 am by jeffreynewmanadmin
Francis Health System, Inc. pays $36.5 million to settle False Claims Act and Anti-kickback case appeared first on Jeff Newman Law. [read post]
12 Jun 2017, 9:59 pm by Patent Docs
Amgen Inc., marking the first time the Court has interpreted the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
19 Aug 2018, 9:59 pm by Patent Docs
Seeking approval to market a generic version of Aveed®, a long-acting injectable testosterone replacement therapy for men suffering from physiologically... [read post]
25 Nov 2015, 9:59 pm by Patent Docs
Noonan -- The question of the extent to which the "safe harbor" against infringement as part of the Hatch-Waxman Act (set forth in 35 U.S.C § 271(e)(1)) extends to activities post-generic drug approval is unresolved, as evidenced by the different conclusions in Classen Immunotherapies, Inc. v. [read post]
23 Sep 2012, 9:11 pm by Cynthia Marcotte Stamer
HCA Inc., one of the nation’s largest for-profit hospital chains, has agreed to pay the United States and the state of Tennessee $16.5 million to settle claims that it violated the False Claims Act and the Stark Statute, the Department of Justice announced September 19, 2012. [read post]
25 Apr 2017, 8:43 pm by Patent Docs
Amgen Inc, involving interpretation for the first time of the Biologics Price Competition and Innovation Act ("BPCIA"), which was enacted in 2010 to facilitate the entry of biosimilar drug products into the marketplace. [read post]